Beone Medicines Ltd. Class A · SSE:688235
Wang Xiaodong sold 31,027 Beone Medicines Ltd. Class A shares (Form 4)
Traded Oct 13, 2026 · Filed Oct 15, 2026
On Oct 13, 2026, Wang Xiaodong (Director, Chair, Scientific Advisory Brd) sold 31,027 Beone Medicines Ltd. Class A shares at an average US$350.99 for US$10.9M under a trading plan, leaving 0 shares. Filed Oct 15, 2026 (Form 4).
- Sold
- 31,027 shares
- Price
- US$350.99 average (US$349.56 to US$353.24)
- Value
- US$10.9M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chair, Scientific Advisory Brd
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | American Depositary Shares | Option exercise | 31,027 | US$36.90 | 31,027 | Direct |
| Oct 13, 2026 | American Depositary Shares | Sale | 7,167 | US$349.56 | 23,860 | Direct |
| Oct 13, 2026 | American Depositary Shares | Sale | 10,361 | US$350.47 | 13,499 | Direct |
| Oct 13, 2026 | American Depositary Shares | Sale | 5,681 | US$351.40 | 7,818 | Direct |
| Oct 13, 2026 | American Depositary Shares | Sale | 6,558 | US$352.57 | 1,260 | Direct |
| Oct 13, 2026 | American Depositary Shares | Sale | 1,260 | US$353.24 | 0 | Direct |
Source
Download original · View original at SEC
Related
- Beone Medicines Ltd. Class A
- Wang Xiaodong
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Wang Xiaodong · Sep 10, 2026
- Form 4 · Wang Xiaodong · Jun 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026
- Form 4 · Ball Titus B. · Sep 3, 2026
- Form 4 · Wu Xiaobin · Aug 27, 2026